Recombinant Human C5a anaphylatoxin chemotactic receptor 2 (C5AR2)

What is C5AR2 and how does it differ structurally and functionally from C5AR1?

C5AR2 is the second receptor for the complement activation peptide C5a. While both C5AR1 and C5AR2 are seven-transmembrane domain receptors belonging to the G protein-coupled receptor (GPCR) family, they differ significantly in their signaling mechanisms. The key structural differences include:

• C5AR2 has a leucine residue instead of an arginine in the DRY motif, which is critical for Gα-protein coupling

• C5AR2 lacks serine/threonine residues in the third intracellular loop that mediate G-protein recognition in C5AR1

• C5AR2 has a modified NPXXY motif in the seventh transmembrane helix, which normally acts as an important signal transduction sequence in GPCRs

What are the current methodologies for studying C5AR2-specific functions?

Studying C5AR2-specific functions has been challenging due to the lack of selective ligands. Current methodologies include:

• Selective C5AR2 ligands: Peptides like P32 (Ac-RHYPYWR-OH) and P59 have been identified as functionally selective C5AR2 ligands that can recruit β-arrestin 2 via C5AR2 without activating C5AR1 .

• Knockout mouse models: C5AR2-/- mice have been crucial for determining C5AR2's role in various disease models, including sepsis, allergic asthma, and systemic infection models .

• Cell-based assays: Techniques to measure:

  • β-arrestin 2 recruitment

  • ERK1/2 activation inhibition

  • Modulation of cytokine production in human monocyte-derived macrophages

• In vivo functional assays: For example, measurements of neutrophil mobilization in wild-type versus C5AR2-/- mice in response to C5a .

How is C5AR2 expression regulated across different tissue types?

C5AR2 expression varies significantly across different tissues and cancer types. According to the Human Protein Atlas data and TCGA/GTEx analyses:

• C5AR2 is highly expressed in breast cancer tissues compared to normal breast tissue

• Expression levels differ among breast cancer subtypes, with higher expression in Luminal A and Luminal B (ER-positive) compared to HER2 and Basal (ER-negative) subtypes

• C5AR2 expression is elevated in BRCA, HNSC, LIHC, PCPG, STAD, and THCA cancer types

• It shows decreased expression in BLCA, KIRC, KIRP, LUSC, and THYM cancer types

Expression can be confirmed through immunohistochemistry (IHC) staining, which has shown significantly higher C5AR2 protein expression in breast cancer tissues compared to adjacent normal tissues .

How can researchers reconcile contradictory findings regarding C5AR2's role in different disease models?

C5AR2 demonstrates context-dependent functions across different disease models, which has led to seemingly contradictory findings. To address this, researchers should:

• Consider disease-specific mechanisms: C5AR2 has been shown to be:

  • Detrimental in cecal ligation and puncture-induced sepsis, experimental allergic asthma, dextran sulfate sodium-induced colitis, and renal ischemia reperfusion injury

  • Protective in LPS-induced sepsis and allergic contact dermatitis

  • Conflicting evidence exists for its role in acute lung injury

• Examine cell type-specific effects: C5AR2 functions may vary depending on the predominant cell type involved in the disease process.

• Design experiments with appropriate controls:

  • Compare C5AR2-/- and wild-type mice in the same disease model

  • Use selective C5AR2 ligands (like P32) alongside C5AR1 antagonists

  • Employ cell type-specific conditional knockout models

• Track temporal dynamics: The role of C5AR2 may change during different phases of disease progression, requiring time-course studies.

• Consider interactions with other complement components: C5AR2's effects may depend on the broader complement activation context and interactions with other signaling pathways .

What experimental approaches are most effective for studying C5AR2-mediated immune modulation?

To effectively study C5AR2-mediated immune modulation, researchers should consider:

• Macrophage polarization assays: Since C5AR2 expression correlates strongly with macrophage polarization, particularly the switch between M1 and M2 phenotypes, researchers should:

  • Measure M1/M2 marker expression before and after C5AR2 activation

  • Use flow cytometry to quantify M0, M1, and M2 macrophage populations

  • Assess cytokine profiles characteristic of different macrophage phenotypes

• Receptor signaling analysis:

  • ERK1/2 phosphorylation assays to measure MAPK pathway modulation

  • Calcium mobilization assays to assess effects on C5aR1, C3aR, and CMKLR1 signaling

  • β-arrestin recruitment assays using BRET or FRET technologies

• Cytokine production measurement:

  • Stimulate macrophages with various TLR ligands (TLR2, TLR3, TLR4, TLR7)

  • Activate C-type lectin receptors (Dectin-1, Dectin-2, Mincle)

  • Trigger STING pathways

  • Measure resulting cytokine production with and without C5AR2 activation by P32

• In vivo immune cell recruitment studies:

  • Track neutrophil mobilization in response to C5a challenge

  • Compare responses between wild-type and C5AR2-/- mice

  • Evaluate the impact of selective C5AR2 ligands on immune cell trafficking

How does C5AR2 expression correlate with cancer prognosis and immune infiltration?

C5AR2 has emerged as a potential biomarker in cancer, particularly breast cancer. Research approaches to study this relationship include:

What functional assays best demonstrate C5AR2's effects on cell migration, invasion, and proliferation?

To study C5AR2's effects on cancer cell malignant properties, researchers can employ:

• Cell proliferation assays:

  • CCK8 assay to measure cell viability and proliferation in breast cancer cell lines with C5AR2 overexpression or knockdown

  • Cell cycle analysis using flow cytometry to determine if C5AR2 affects cell cycle progression

• Migration and invasion assays:

  • Transwell migration assay to assess cell motility

  • Matrigel invasion assay to evaluate invasive capacity

  • Wound healing assay to monitor migration in real-time

  • These assays have confirmed that C5AR2 overexpression facilitates migration, invasion, and proliferation in breast cancer cells

• Gene expression correlation studies:

  • Gene set enrichment analysis (GSEA) to identify pathways affected by C5AR2

  • Correlation analysis with known migration and invasion markers

  • RNA sequencing to identify global gene expression changes following C5AR2 modulation

What are the best approaches for developing selective C5AR2 ligands for research applications?

The development of selective C5AR2 ligands has been crucial for advancing our understanding of this receptor. Researchers should consider:

• Peptide library screening approach:

  • Generate libraries based on the C-terminus of C5a (as done with the 61 peptides screened to identify P32 and P59)

  • Test for selective β-arrestin recruitment via C5AR2

  • Confirm lack of activity at C5AR1

• Functional selectivity characterization:

  • Assess ERK1/2 activation inhibition

  • Measure effects on lipopolysaccharide-stimulated cytokine release

  • Confirm receptor specificity by comparing effects in wild-type versus C5AR2-/- models

• Structure-activity relationship studies:

  • Analyze how modifications to peptide sequence affect selectivity

  • Optimize peptide stability for in vivo applications

  • Develop non-peptide small molecule modulators based on active peptide structures

• Validation criteria for C5AR2 selectivity:

  • Must demonstrate selective recruitment of β-arrestin 2 via C5AR2

  • Should inhibit C5a-induced ERK1/2 activation

  • Must not induce ERK1/2 activation via C5AR1

  • Should produce effects in wild-type but not C5AR2-/- mice

How can C5AR2 be targeted in inflammatory disease models?

C5AR2 represents a potential therapeutic target in inflammatory diseases, with research approaches including:

• Infectious disease models:

  • In systemic Listeria monocytogenes infection, C5AR2-/- mice show a protective phenotype, indicating C5AR2 is harmful during this bacterial infection

  • Compare bacterial burden, inflammatory cytokine levels, and survival between wild-type and C5AR2-/- mice

• Inflammatory disease models:

  • For sepsis models, monitor outcomes in cecal ligation and puncture versus LPS-induced sepsis, as C5AR2 has opposing roles in these models

  • In experimental allergic asthma, dextran sulfate sodium-induced colitis, and renal ischemia reperfusion injury, C5AR2 inhibition may be beneficial

• Cellular inflammation models:

  • Use C5AR2 selective agonists like P32 to modulate TLR-mediated inflammation

  • Particularly focus on C-type lectin receptor pathways, as C5AR2 activation can reduce Mincle-mediated IL-6 and TNF-α generation by 80-90%

What is the current evidence for C5AR2's role in tumor progression?

Evidence for C5AR2's role in tumor progression comes from several approaches:

• Expression analysis in cancer tissues:

  • C5AR2 is highly expressed in breast cancer compared to normal breast tissue

  • Expression varies across cancer subtypes, with higher levels in ER-positive subtypes

• Prognostic correlation studies:

  • High C5AR2 expression correlates with poor prognosis in multiple cancers:

    • Breast cancer (BRCA)

    • Glioblastoma (GBM)

    • Kidney chromophobe (KICH)

    • Acute myeloid leukemia (LAML)

    • Brain lower grade glioma (LGG)

    • Liver hepatocellular carcinoma (LIHC)

    • Pancreatic adenocarcinoma (PAAD)

    • Stomach adenocarcinoma (STAD)

• Functional studies in cancer cells:

  • C5AR2 overexpression promotes migration, invasion, and proliferation in breast cancer cells

  • These findings align with bioinformatic analyses showing C5AR2's role in tumorigenesis

• Immune microenvironment analysis:

  • C5AR2 expression strongly correlates with M2 macrophage infiltration, which typically promotes tumor progression

  • This suggests C5AR2 may facilitate an immunosuppressive tumor microenvironment

What techniques are most effective for studying C5AR2 expression and localization in tissues?

To effectively study C5AR2 expression and localization, researchers should employ:

• Immunohistochemistry (IHC):

  • Validated in breast cancer tissues showing significantly higher expression compared to adjacent normal tissues

  • Allows visualization of protein expression patterns within tissue context

  • Can reveal subcellular localization and cell-type specific expression

• Transcriptomic analysis:

  • RNA-seq data from TCGA and GTEx databases provide comprehensive expression profiles across cancer types

  • Can identify cancer types with altered C5AR2 expression (elevated in BRCA, CHOL, ESCA, GBM, etc.)

• Single-cell RNA sequencing:

  • Provides cell-type specific expression patterns

  • Can reveal heterogeneity of C5AR2 expression within tumors

  • Helps identify which specific immune cell populations express C5AR2

• Flow cytometry:

  • Quantitative assessment of C5AR2 expression on different immune cell populations

  • Can be combined with functional assays to correlate expression with cellular responses

  • Useful for analyzing infiltrating immune cells like macrophage subsets

How should researchers interpret contradictory data about C5AR2 signaling mechanisms?

When facing contradictory data about C5AR2 signaling, researchers should:

• Consider cell type-specific effects:

  • C5AR2 may signal differently in neutrophils versus macrophages

  • Primary cells may behave differently than cell lines

  • Expression levels of interacting proteins may vary between models

• Evaluate experimental contexts:

  • C5AR2 signaling may depend on activation status of cells

  • Co-stimulation with other receptors may alter signaling outcomes

  • Temporal dynamics may explain different observations at different time points

• Isolate C5AR2-specific effects:

  • Use selective ligands like P32 that show no activity at C5AR1

  • Confirm findings in C5AR2-/- models to ensure specificity

  • Compare with known C5AR1 antagonists to distinguish receptor-specific effects

• Focus on β-arrestin pathways:

  • Since C5AR2 can recruit β-arrestin but cannot signal through G proteins, investigate β-arrestin-dependent signaling

  • Examine how C5AR2 modulates C5AR1-mediated β-arrestin recruitment

  • Consider β-arrestin-dependent but G protein-independent cellular responses

What statistical approaches are most appropriate for analyzing C5AR2 expression data in relation to patient outcomes?

For analyzing C5AR2 expression in relation to patient outcomes, researchers should employ:

• Survival analysis methods:

  • Kaplan-Meier survival curves with log-rank tests to compare high versus low C5AR2 expression groups

  • Cox proportional hazards model to calculate hazard ratios (HR) and 95% confidence intervals (CI)

  • Adjust for known prognostic factors to isolate C5AR2's independent prognostic value

• Expression categorization approaches:

  • Bipartite method to distribute C5AR2 expression into high and low groups

  • Consider continuous expression analysis to avoid arbitrary cutoffs

  • Test multiple cutoff points to ensure robustness of findings

• Cancer subtype-specific analysis:

  • Stratify by molecular subtypes (e.g., ER-positive versus ER-negative breast cancer)

  • Analyze within treatment groups to identify potential predictive value

  • Consider tumor stage and grade in stratification

• Correlation with immune infiltration:

  • Use Spearman's rank correlation coefficient to assess relationships with immune cell infiltration

  • Apply multiple immune deconvolution methods (CIBERSORT, QUANTISEQ, XCELL)

  • Compare infiltration scores between high and low C5AR2 expression groups

What are the key considerations when designing experiments to study C5AR2 and C5AR1 interactions?

When studying C5AR2 and C5AR1 interactions, researchers should consider:

• Receptor expression levels:

  • Quantify relative expression of both receptors in model systems

  • Consider using cell lines with defined receptor expression ratios

  • Create systems with selective knockdown/overexpression of each receptor

• Selective activation approaches:

  • Use C5AR2-selective agonists (P32, P59) that don't activate C5AR1

  • Compare with C5AR1-selective agonists

  • Use sequential stimulation protocols to examine how activation of one receptor affects responses to the other

• β-arrestin recruitment dynamics:

  • Examine how C5AR2 modulates β-arrestin recruitment to C5AR1

  • Investigate competition for β-arrestin between receptors

  • Study temporal aspects of β-arrestin recruitment to each receptor

• Downstream signaling analysis:

  • Focus on ERK1/2 activation as a key readout

  • Examine calcium mobilization as a G protein-dependent response

  • Compare signaling patterns with various receptor activation combinations

• Functional outcomes assessment:

  • Measure effects on cytokine production

  • Assess neutrophil mobilization in response to C5a

  • Compare responses in systems with both receptors versus those with only one

What are the most promising therapeutic applications for C5AR2 modulation?

Based on current research, promising therapeutic applications for C5AR2 modulation include:

• Inflammatory disease treatment:

  • Selective C5AR2 activation in conditions where it shows protective effects (LPS-induced sepsis, allergic contact dermatitis)

  • C5AR2 inhibition in conditions where it's detrimental (cecal ligation and puncture-induced sepsis, experimental allergic asthma)

• Cancer immunotherapy:

  • C5AR2 antagonism in breast cancer and other malignancies where high expression correlates with poor prognosis

  • Combination with strategies targeting tumor-associated macrophages, given C5AR2's role in macrophage polarization

  • Potential biomarker for patient stratification in immunotherapy trials

• Modulation of innate immune responses:

  • C5AR2 activation to dampen excessive inflammation through its broad effects on TLR and C-type lectin receptor signaling

  • Particularly promising for conditions with overwhelming cytokine production

  • May be especially effective at modulating Mincle-mediated responses

What novel techniques might advance our understanding of C5AR2 biology?

Emerging techniques that could advance C5AR2 research include:

• CRISPR-based approaches:

  • Generate precise structural variants of C5AR2 to determine key functional domains

  • Create cell type-specific conditional knockout models

  • Develop reporter systems for real-time monitoring of C5AR2 activation

• Single-cell multi-omics:

  • Combine single-cell RNA-seq with proteomics to correlate C5AR2 expression with cellular phenotypes

  • Map C5AR2 expression across tissue and immune cell landscapes

  • Identify novel cell populations where C5AR2 plays important roles

• Advanced imaging techniques:

  • Use super-resolution microscopy to visualize C5AR2-C5AR1 interactions

  • Apply intravital microscopy to track C5AR2-expressing cells in vivo

  • Develop C5AR2-specific tracers for molecular imaging

• Phosphoproteomic analysis:

  • Map signaling networks downstream of C5AR2 activation

  • Compare phosphorylation patterns between C5AR1 and C5AR2 stimulation

  • Identify novel signaling nodes that might explain C5AR2's diverse functions